Trump’s 200% tariff threat leaves pharma firms scrambling with scenario planning

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Leave a Reply

Your email address will not be published. Required fields are marked *